{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:07:09Z","timestamp":1780510029083,"version":"3.54.1"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI179046"],"award-info":[{"award-number":["R01AI179046"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FDA","award":["75F40123C00128"],"award-info":[{"award-number":["75F40123C00128"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["2RO1 AI130060"],"award-info":[{"award-number":["2RO1 AI130060"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Carbapenem-resistant\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    (CRAB), a Gram-negative bacterial pathogen, has been identified by Centers for Disease Control (CDC) as the top priority pathogen for which new antibiotics are needed. We found that the addition of bicarbonate at physiologically normal levels found in the blood (23.8\u2009mM) increased susceptibility of\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    clinical isolates (n\u2009=\u200963) to azithromycin and resulted in MIC50 shift from 64\u2009mg\/L in CAMHB to 1\u20132\u2009mg\/L in CAMHB\u2009+\u2009bicarbonate (23.8\u2009mM) or RPMI-1640 respectively. To characterize\n                    <jats:italic>in vivo<\/jats:italic>\n                    efficacy in murine blood and lung infection models, mice were infected with\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    and then mice were treated with a human equivalent dosing strategy of azithromycin.\n                    <jats:italic>In vivo<\/jats:italic>\n                    outcomes greatly depended on the infection model used. The bloodstream infection model showed a statistically significant increase in survival of the treatment group compared to the control group. However, that was not found with the oral aspiration infection model. We hypothesize that these\n                    <jats:italic>in vivo<\/jats:italic>\n                    results are due to the local differences of bicarbonate concentrations at the site of infection throughout the course of infection.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0350230","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:26:55Z","timestamp":1780507615000},"page":"e0350230","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterizing the in vitro and in vivo effect of bicarbonate on azithromycin activity against Acinetobacter baumannii"],"prefix":"10.1371","volume":"21","author":[{"given":"Hadley","family":"Jaramillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Slarve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2565-6079","authenticated-orcid":true,"given":"Derek","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Zorawik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Goy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Popel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Spellberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6718-4551","authenticated-orcid":true,"given":"Brian","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"pone.0350230.ref001","unstructured":"Centers for Disease Control and Prevention. Outpatient Antibiotic Prescriptions \u2014 United States, 2020. 2020. https:\/\/www.cdc.gov\/antibiotic-use\/pdfs\/Annual-Report-2020-H.pdf"},{"key":"pone.0350230.ref002","doi-asserted-by":"crossref","unstructured":"Kaneko T, Dougherty TJ, Magee TV. Macrolide Antibiotics. 2007. p. 519\u201366.","DOI":"10.1016\/B0-08-045044-X\/00219-4"},{"issue":"18","key":"pone.0350230.ref003","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1111\/bph.13936","article-title":"The macrolide antibiotic renaissance","volume":"174","author":"GP Dinos","year":"2017","journal-title":"Br J Pharmacol"},{"key":"pone.0350230.ref004","year":"2022","edition":"32"},{"key":"pone.0350230.ref005","doi-asserted-by":"crossref","first-page":"1264492","DOI":"10.3389\/fmed.2023.1264492","article-title":"Case report: Azithromycin-meropenem combination therapy as a low-cost approach to combat PDR gram-negative infections of war wounds in Ukraine","volume":"10","author":"V Kryzhevskyi","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"pone.0350230.ref006","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41564-020-0737-6","article-title":"A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii","volume":"5","author":"B Luna","year":"2020","journal-title":"Nat Microbiol"},{"issue":"6","key":"pone.0350230.ref007","article-title":"In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae","volume":"6","author":"B Lee","year":"2021","journal-title":"mSphere"},{"issue":"3","key":"pone.0350230.ref008","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/acsinfecdis.7b00194","article-title":"Bicarbonate Alters Bacterial Susceptibility to Antibiotics by Targeting the Proton Motive Force","volume":"4","author":"MA Farha","year":"2018","journal-title":"ACS Infect Dis"},{"issue":"10","key":"pone.0350230.ref009","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1021\/acsinfecdis.0c00340","article-title":"Overcoming Acquired and Native Macrolide Resistance with Bicarbonate","volume":"6","author":"MA Farha","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"1","key":"pone.0350230.ref010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1021\/acsinfecdis.5c00582","article-title":"Evaluation of Azithromycin-Bicarbonate against Multidrug-Resistant Pathogens in Topical Murine Models of Infection","volume":"12","author":"MA Farha","year":"2026","journal-title":"ACS Infect Dis"},{"issue":"1","key":"pone.0350230.ref011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/infdis\/jiaf480","article-title":"Investigating Azithromycin Activity Against ESBL-Producing Escherichia coli Under Physiologically Relevant Conditions","volume":"233","author":"S Jung","year":"2026","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0350230.ref012","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jac\/dkae455","article-title":"NaHCO3 modulates the bla operon and \u03b2-lactam susceptibility in borderline oxacillin-resistant Staphylococcus aureus (BORSA)","volume":"80","author":"SC Ersoy","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"pone.0350230.ref013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ebiom.2019.07.041","article-title":"Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens","volume":"46","author":"N Dillon","year":"2019","journal-title":"EBioMedicine"},{"key":"pone.0350230.ref014","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2017.05.026","article-title":"Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing","volume":"20","author":"SC Ersoy","year":"2017","journal-title":"EBioMedicine"},{"issue":"1","key":"pone.0350230.ref015","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01320-22","article-title":"Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts In Vivo Outcomes in Galleria mellonella","volume":"67","author":"S Miller","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"pone.0350230.ref016","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00725-24","article-title":"Polymyxins retain in vitro activity and in vivo efficacy against \u201cresistant\u201d Acinetobacter baumannii strains when tested in physiological conditions","volume":"68","author":"J Rubio","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0350230.ref017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02204-20","article-title":"Synergistic rifabutin and colistin reduce emergence of resistance when treating Acinetobacter baumannii","volume":"65","author":"J Cheng","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"pone.0350230.ref018","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1093\/jac\/dkz225","article-title":"Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria","volume":"74","author":"BM Luna","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"pone.0350230.ref019","first-page":"1296","article-title":"Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia","volume":"211","author":"KW Bruhn","year":"2015","journal-title":"J Infect Dis"},{"issue":"7","key":"pone.0350230.ref020","article-title":"Natural history of Acinetobacter baumannii infection in mice","volume":"14","author":"BM Luna","year":"2019","journal-title":"PLoS One"},{"key":"pone.0350230.ref021","article-title":"Murine oropharyngeal aspiration model of ventilator-associated and hospital-acquired bacterial pneumonia","author":"TB Nielsen","year":"2018","journal-title":"J Vis Exp"},{"issue":"7","key":"pone.0350230.ref022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00239-18","article-title":"Assessment of the In Vivo Activity of SPR741 in combination with azithromycin against multidrug-resistant enterobacteriaceae isolates in the neutropenic murine thigh infection model","volume":"62","author":"SM Stainton","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"pone.0350230.ref023","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1093\/jac\/dku207","article-title":"Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data","volume":"69","author":"GG Zhanel","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"pone.0350230.ref024","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.1991.261.5.C727","article-title":"Mechanisms and regulation of ion transport in adult mammalian alveolar type II pneumocytes","volume":"261","author":"S Matalon","year":"1991","journal-title":"Am J Physiol"},{"key":"pone.0350230.ref025","doi-asserted-by":"crossref","DOI":"10.1086\/321854","article-title":"Does the dose matter?","volume":"33","author":"WA Craig","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0350230.ref026","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/antibiotics9050218","article-title":"Increased azithromycin susceptibility of multidrug-resistant gram-negative bacteria on RPMI-1640 agar assessed by disk diffusion testing","volume":"9","author":"M Meerwein","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"pone.0350230.ref027","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","article-title":"Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens","volume":"2","author":"L Lin","year":"2015","journal-title":"EBioMedicine"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:27:03Z","timestamp":1780507623000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350230"}},"subtitle":[],"editor":[{"given":"Livia","family":"Leoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350230","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}